Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Sullivan

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Clinical Genetics|August 27, 2019
The genome empowerment scale: An assessment of parental empowerment in families with undiagnosed diseaseAllyn McConkie-Rosell, Kelly Schoch, Jennifer Sullivan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Demonstration of feasibility of in vivo gene therapy for Gaucher disease using a chemically induced mouse modelJohn Marshall, Kerry Anne McEachern, Julie A Cavanagh Kyros, et al.
Blood|November 21, 2007
Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivoMelanie C Ruzek, James S Waire, Deborah Hopkins, et al.
The Journal of Urology|January 23, 2010
Stone forming risk factors in patients with type Ia glycogen storage diseaseCharles D Scales, Aravind S Chandrashekar, Marnie R Robinson, et al.
Human Mutation|July 3, 2019
Heterozygous variants in MYBPC1 are associated with an expanded neuromuscular phenotype beyond arthrogryposisVandana Shashi, Janelle Geist, Youngha Lee, et al.
American Journal of Human Genetics|March 6, 2026
Newborn screening for type 1 diabetes using genome-based risk scores in the Early Check programNathan C Gaddis, Katerina S Kucera, Heidi L Cope, et al.
Open Forum Infectious Diseases|October 11, 2021
Demographics and Clinical Characteristics of Adult Patients Hospitalized due to COVID-19 in a Rural/Suburban Integrated Health System in Southcentral Pennsylvania, March Through May 2020Michael A Bohrn, Ronald Benenson, Chelsea M Bush, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2018
Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNSJerusha Naidoo, Lisa M Stanek, Kousaku Ohno, et al.
Human Molecular Genetics|November 20, 2024
De novo missense variants in the PP2A regulatory subunit PPP2R2B in a neurodevelopmental syndrome: potential links to mitochondrial dynamics and spinocerebellar ataxiasPriyanka Sandal, Chian Ju Jong, Ronald A Merrill, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2025
Development of an AAV-delivered microRNA gene therapy for Myotonic Dystrophy Type 1Giulio S Tomassy, Wei Fan, Shuwen Cao, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Clinical Genetics|August 27, 2019
The genome empowerment scale: An assessment of parental empowerment in families with undiagnosed diseaseAllyn McConkie-Rosell, Kelly Schoch, Jennifer Sullivan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Demonstration of feasibility of in vivo gene therapy for Gaucher disease using a chemically induced mouse modelJohn Marshall, Kerry Anne McEachern, Julie A Cavanagh Kyros, et al.
Blood|November 21, 2007
Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivoMelanie C Ruzek, James S Waire, Deborah Hopkins, et al.
The Journal of Urology|January 23, 2010
Stone forming risk factors in patients with type Ia glycogen storage diseaseCharles D Scales, Aravind S Chandrashekar, Marnie R Robinson, et al.
Human Mutation|July 3, 2019
Heterozygous variants in MYBPC1 are associated with an expanded neuromuscular phenotype beyond arthrogryposisVandana Shashi, Janelle Geist, Youngha Lee, et al.
American Journal of Human Genetics|March 6, 2026
Newborn screening for type 1 diabetes using genome-based risk scores in the Early Check programNathan C Gaddis, Katerina S Kucera, Heidi L Cope, et al.
Open Forum Infectious Diseases|October 11, 2021
Demographics and Clinical Characteristics of Adult Patients Hospitalized due to COVID-19 in a Rural/Suburban Integrated Health System in Southcentral Pennsylvania, March Through May 2020Michael A Bohrn, Ronald Benenson, Chelsea M Bush, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2018
Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNSJerusha Naidoo, Lisa M Stanek, Kousaku Ohno, et al.
Human Molecular Genetics|November 20, 2024
De novo missense variants in the PP2A regulatory subunit PPP2R2B in a neurodevelopmental syndrome: potential links to mitochondrial dynamics and spinocerebellar ataxiasPriyanka Sandal, Chian Ju Jong, Ronald A Merrill, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2025
Development of an AAV-delivered microRNA gene therapy for Myotonic Dystrophy Type 1Giulio S Tomassy, Wei Fan, Shuwen Cao, et al.
Pageof 6